Evaluation of cell‐free seminal mRNA for the diagnosis of obstruction as the cause of azoospermia in infertile men: A prospective cohort study. (9th August 2022)

• Record Type: Journal Article
• Authors: Goel, Ritesh; Batra, Harish; Kumar, Manoj; Dada, Rima; Kumar, Rajeev
• Is Part Of: Andrologia. Volume 54:Number 9(2022)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2022-08-09
• Subjects: azoospermia -- DDX4 -- infertility -- protamine -- seminal mRNA; Andrology -- Periodicals; Infertility, Male -- Periodicals; 616.69
• DOI: 10.1111/and.14364
• Languages: English
• ISSNs: 0303-4569

Abstract

Abstract: Differentiating obstructive (OA) from non‐obstructive (NOA) azoospermia is clinically important in managing infertile men. Classically, the differentiation has been based on clinical, hormonal and histological analysis. Histological tests are invasive and may miss spermatogenic areas. Seminal fluid can serve as a medium to assess the status of spermatogenesis and presence or absence of certain markers can help diagnosing and differentiating azoospermia. We evaluated the role of cell‐free seminal markers: DDX4, PRM1 and PRM2 in diagnosing and differentiating between OA and NOA and classifying their subtypes. We observed DDX4 was more sensitive for NOA compared with OA. Among various subtypes of NOA, DDX4 positivity was higher in patients with maturation arrest and hypospermatogenesis compared with Sertoli cell only syndrome. PRM1 and PRM2 had very low positivity rate for any meaningful comparison. Seminal cell‐free markers can serve as non‐invasive tests in diagnosing and differentiating etiologies of azoospermia but their validity needs to be proved in long‐term trials with more refined molecular techniques.